Skip to main content

In Print: Last Week's Clinical Sequencing Papers of Note: Nov 1, 2012


Exome sequencing identified a missense mutation of EPS8L3 in Marie Unna hereditary hypotrichosis.
Zhang X, Guo BR, Cai LQ, Jiang T, et al.
J Med Genet. 2012 Oct 25. [Epub ahead of print]

Comparison of the gene expression profiles between smokers with and without lung cancer using RNA-seq.
Cheng P, Cheng Y, Li Y, Zhao Z, et al.
Asian Pac J Cancer Prev. 2012;13(8):3605-9.

Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus.
Levinsohn JL, Tian LC, Boyden LM, McNiff JM, et al.
J Invest Dermatol. 2012 Oct 25. [Epub ahead of print]

EVA: Exome Variation Analyzer, an efficient and versatile tool for filtering strategies in medical genomics.
Coutant S, Cabot C, Lefebvre A, Léonard M, et al.
BMC Bioinformatics. 2012;13 Suppl 14:S9.

Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE.
Nava C, Lamari F, Héron D, Mignot C, et al.
Transl Psychiatry. 2012 Oct 23;2:e179.

Adoptive transfer of autologous T cells improves T cell repertoire diversity and long term B cell function in pediatric patients with neuroblastoma.
Grupp SA, Luning Prak E, Boyer J, McDonald KR, et al.
Clin Cancer Res. 2012 Oct 23. [Epub ahead of print]

Rapid detection and identification of Yersinia pestis from food using immunomagnetic separation and pyrosequencing.
Amoako KK, Shields MJ, Goji N, Paquet C, et al.
J Pathog. 2012;2012:781652. Epub 2012 Oct 3.

Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in anti-apoptotic and chromatin-remodeling genes.
Giulino-Roth L, Wang K, Macdonald TY, Mathew S, et al.
Blood. 2012 Oct 22. [Epub ahead of print]

Autozygosity mapping with exome sequence data.
Carr IM, Bhaskar S, O' Sullivan J, Aldhamesh MA, et al.
Hum Mutat. 2012 Oct 22. [Epub ahead of print]

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.